TW
BMY icon

TrinityPoint Wealth’s Bristol-Myers Squibb BMY Stock Holding History

TrinityPoint Wealth’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$450K Buy
7,948
+1,398
+21% +$78.1K 0.06% 235
2024
Q3 		$339K Buy
6,550
+522
+9% +$24.5K 0.05% 252
2024
Q2 		$250K Sell
6,028
-743
-11% -$33.2K 0.04% 275
2024
Q1 		$367K Sell
6,771
-1,357
-17% -$69.1K 0.06% 225
2023
Q4 		$417K Sell
8,128
-29,722
-79% -$1.56M 0.08% 209
2023
Q3 		$2.2M Buy
37,850
+1,113
+3% +$68.2K 0.44% 61
2023
Q2 		$2.35M Buy
36,737
+28,210
+331% +$1.89M 0.46% 62
2023
Q1 		$591K Buy
8,527
+578
+7% +$40.8K 0.13% 158
2022
Q4 		$572K Buy
7,949
+631
+9% +$47.6K 0.13% 153
2022
Q3 		$520K Buy
7,318
+1,729
+31% +$125K 0.12% 154
2022
Q2 		$430K Buy
5,589
+714
+15% +$54.4K 0.1% 176
2022
Q1 		$356K Buy
4,875
+1,494
+44% +$100K 0.06% 220
2021
Q4 		$211K Buy
+3,381
New +$198K 0.04% 293
2020
Q1 		– Sell
-3,154
Closed -$202K – 195
2019
Q4 		$202K Buy
+3,154
New +$181K 0.07% 205
2019
Q2 		– Sell
-31,652
Closed -$1.51M – 173
2019
Q1 		$1.51M Buy
31,652
+5,845
+23% +$291K 0.74% 35
2018
Q4 		$1.34M Buy
+25,807
New +$1.39M 0.82% 29

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TrinityPoint Wealth's BMY Position: Q4 2024 in Review

TrinityPoint Wealth increased its Bristol-Myers Squibb (BMY) stake by 21% in Q4 2024, buying an estimated $78.1K and bringing the position to 7,948 shares worth $450K. The position accounts for 0.06% of the portfolio, ranked #235.

TrinityPoint Wealth first reported a position in BMY in Q4 2018 and has held it in 16 quarters since. The position peaked at $2.35M in Q2 2023. 2,486 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

  • TrinityPoint Wealth held 7,948 shares of Bristol-Myers Squibb worth $450K as of Q4 2024.
  • TrinityPoint Wealth bought 1,398 Bristol-Myers Squibb shares in Q4 2024, an estimated $78.1K.
  • Bristol-Myers Squibb made up 0.06% of TrinityPoint Wealth's portfolio in Q4 2024, its #235 holding.
  • TrinityPoint Wealth first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 16 quarters since.
  • TrinityPoint Wealth's Bristol-Myers Squibb position peaked at $2.35M in Q2 2023.
  • 2,486 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on TrinityPoint Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.